Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
R.S. Bedlack, Paul Wicks, Timothy Vaughan, Alicia Opie, Rebecca Blum, Amanda Dios & Ghazaleh Sadri-Vakili. (2019) Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 285-293.
Read now
Read now
Daniel Harrison, Paul Mehta, Michael A. van Es, Elijah Stommel, Vivian E. Drory, Beatrice Nefussy, Leonard H. van den Berg, Jesse Crayle & Richard Bedlack. (2018) “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 495-499.
Read now
Read now
Articles from other publishers (4)
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, Christopher J. McDermott, Orla Hardiman, Jeremy M. Shefner, Ammar Al-Chalabi, William Huynh, Merit Cudkowicz, Paul Talman, Leonard H. Van den Berg, Thanuja Dharmadasa, Paul Wicks, Claire Reilly & Martin R. Turner. (2020) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nature Reviews Neurology 17:2, pages 104-118.
Crossref
Crossref
Christopher G. TarolliGrace A. ZimmermanSteven GoldenthalBlake FeldmanSarah BerkBernadette SiddiqiCatherine M. KopilSohini ChowdhuryKevin M. BiglanE. Ray DorseyJamie L. Adams. (2020) Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants. Neurology Clinical Practice 10:1, pages 7-14.
Crossref
Crossref
Coco Newton. 2020. Integrative and Functional Medical Nutrition Therapy. Integrative and Functional Medical Nutrition Therapy
863
912
.
Yorick Janssens, Evelien Wynendaele, Wim Vanden Berghe & Bart De Spiegeleer. (2019) Peptides as epigenetic modulators: therapeutic implications. Clinical Epigenetics 11:1.
Crossref
Crossref